logo
Plus   Neg
Share
Email

STADA FY17 Net Profit Down, Cuts Dividend; Sees Growth Ahead - Quick Facts

STADA Arzneimittel AG (STDAY.PK,STDAF.PK), a pharmaceutical company, reported Thursday that its fiscal 2017 net income reduced 1% to 85.3 million euros from 85.9 million euros last year. Earnings per share were 1.37 euros, down from 1.38 euros a year ago.

Adjusted net income was 195.6 million euros or 3.14 euros per share, compared to 177 million euros or 2.85 euros per share a year ago, mainly reflecting positive development of the operating profit in Belgium, Germany, Spain and Russia.

The adjusted EBITDA increased 9% to 433.9 million euros.

Group sales increased 8% to 2.31 billion euros from prior year's 2.13 billion euros. This rise was mainly due to the increase in the Belgian, Italian and Serbian Generics segment as well as in the Russian Branded Products segment. Group sales adjusted by currency and portfolio effects increased by 6%.

Further, STADA targets to accelerate growth and increase its ranking position in the global pharma market in the coming years. To achieve this target the Executive Board and the Supervisory Board of STADA consider it necessary, to significantly increase investments in R&D, new products, technologies and markets.

Against this backdrop, both bodies suggest to the General Meeting on June 6, 2018, to pay a dividend for the 2017 financial year of 0.11 euro per STADA share, down from previous year's 0.72 euro.

Looking ahead, the Executive Board expects further Group growth for financial year 2018 as compared to the prior year. Group sales adjusted for currency and portfolio effects are expected to be 2.495 billion euros plus or minus 5%, representing a growth in the high single digits adjusted for currency and portfolio effects. Adjusted EBITDA is expected to be 480 million euros plus or minus 5% and adjusted net income 230 million euros plus or minus 5%.

With regard to the strategic outlook for 2019, the Executive Board expects to be able to achieve adjusted Group sales of 2.575 billion euros bn plus or minus 5%, an adjusted EBITDA of 540 million euros plus or minus 5% and adjusted net income of 275 million euros plus or minus 5%.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After coming under pressure early in the session, stocks regained some ground over the course of the trading day on Friday. The major averages climbed well off their lows of the session, with the S&P 500 briefly turning positive. President Donald Trump's former campaign chairman Paul Manafort is headed to jail after his bail was revoked by a District Court Judge on Friday. Manafort will remain in jail as he awaits trial on criminal charges related to his lobbying work for a pro-Russia party in Ukraine. Dealing a major blow to House Republican leaders that spent weeks crafting compromise immigration legislation, President Donald Trump declared Friday that he will not sign the bill. The comments from Trump come after House Speaker Paul Ryan, R-Wis., staved off a revolt by some moderate Republicans...
Follow RTT